T005 HHSN26100008 (Old 000509388-T009)TORFP 2018-E03 Prevention of Urinary Bladder Cancer with Two "Clinically-Ready" Agents (Everolimus and Naproxen) when Administered in Combination

Grant

Awarded By

Total Award Amount

  • 0.00

    • Direct Costs

  • 0.00

    • Sponsor Award Id

  • HHSN261201500036I

    • Contributor

  • Gregory Kennedy M.D.   Principal Investigator